The role of fetal hemoglobin-enhancing agents in thalassemia

Seminars in Hematology

Volumn 41, Issue SUPPL. 6, 2004, Pages 17-22

  Lal, Ashutosh ^a   Vichinsky, Elliott ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA GLOBIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; AZACITIDINE; DNA METHYLTRANSFERASE INHIBITOR; ENZYME INHIBITOR; HEMOGLOBIN F; HISTONE DEACETYLASE INHIBITOR; HYDROXYUREA; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; BETA THALASSEMIA; BONE MARROW SUPPRESSION; CARCINOGENESIS; CHROMOSOME VARIANT; CONFERENCE PAPER; DRUG RESPONSE; ERYTHROPOIESIS; GLOBIN SYNTHESIS; HEMOGLOBIN SYNTHESIS; HUMAN; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; SECOND CANCER; SICKLE CELL ANEMIA; SIDE EFFECT; THALASSEMIA; THROMBOCYTOSIS;

AZACITIDINE; FETAL HEMOGLOBIN; HUMANS; THALASSEMIA; TREATMENT OUTCOME;

EID: 7644240657     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.08.004     Document Type: Conference Paper

References (40)

1. A.W. Nienhuis, T.J. Ley, R.K. Humphries Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia Ann N Y Acad Sci 445 1985 198 211
2. G.F. Atweh, J. DeSimone, Y. Saunthararajah Hemoglobinopathies Hematology (Am Soc Hematol Educ Program): 2003 14 39
3. N.F. Olivieri, D.J. Weatherall The therapeutic reactivation of fetal haemoglobin Hum Mol Genet 7 1998 1655 1658
4. M.H. Steinberg, F. Barton, O. Castro Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia Risks and benefits up to 9 years of treatment JAMA 289 2003 1645 1651
5. S. Charache, M.L. Terrin, R.D. Moore Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia N Engl J Med 332 1995 1317 1322
6. H.F. Bunn Induction of fetal hemoglobin in sickle cell disease Blood 93 1999 1787 1789
7. M.H. Steinberg, G.P. Rodgers Pharmacologic modulation of fetal hemoglobin Medicine (Baltimore) 80 2001 328 344
8. D.J. Weatherall Pathophysiology of thalassaemia Baillieres Clin Haematol 11 1998 127 146
9. S.L. Schrier Pathophysiology of thalassemia Curr Opin Hematol 9 2002 123 126
10. D.J. Weatherall Phenotype-genotype relationships in monogenic disease Lessons from the thalassaemias Nat Rev Genet 2 2001 245 255
11. S. Charache, J.B. Clegg, D.J. Weatherall The Negro variety of hereditary persistence of fetal haemoglobin is a mild form of thalassaemia Br J Haematol 34 1976 527 534
12. D.J. Weatherall, J.B. Clegg The Thalassemia Syndromes (ed 4) 2001 Blackwell Science Oxford, UK
13. D.C. Rees, J.B. Porter, J.B. Clegg Why are hemoglobin F levels increased in HbE/beta thalassemia? Blood 94 1999 3199 3204
14. C. Garner, T. Tatu, J.E. Reittie Genetic influences on F cells and other hematologic variables A twin heritability study Blood 95 2000 342 346
15. S.L. Thein Genetic insights into the clinical diversity of beta thalassaemia Br J Haematol 124 2004 264 274
16. J.E. Craig, J. Rochette, C.A. Fisher Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach Nat Genet 12 1996 58 64
17. G.J. Dover, K.D. Smith, Y.C. Chang Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2 Blood 80 1992 816 824
18. N.F. Olivieri Reactivation of fetal hemoglobin in patients with beta-thalassemia Semin Hematol 33 1996 24 42
19. C.H. Lowrey, A.W. Nienhuis Brief report Treatment with azacytidine of patients with end-stage beta-thalassemia N Engl J Med 329 1993 845 848
20. L. Styles, B. Lewis, D. Foote Preliminary report Hydroxyurea produces significant clinical response in thalassemia intermedia Ann N Y Acad Sci 850 1998 461 462
21. M. Alebouyeh, F. Moussavi, H. Haddad-Deylami Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening Ann Hematol 83 2004 430 433
22. M. Bradai, M.T. Abad, S. Pissard Hydroxyurea can eliminate transfusion requirements in children with severe beta-thalassemia Blood 102 2003 1529 1530
23. M. Kohli-Kumar, H. Marandi, M.A. Keller Use of hydroxyurea and recombinant erythropoietin in management of homozygous beta0 thalassemia J Pediatr Hematol Oncol 24 2002 777 778
24. P. Rigano, L. Manfre, R. La Galla Clinical and hematological response to hydroxyurea in a patient with Hb Lepore/beta-thalassemia Hemoglobin 21 1997 219 226
25. E.A. Rachmilewitz, M. Aker The role of recombinant human erythropoietin in the treatment of thalassemia Ann N Y Acad Sci 850 1998 129 138
26. G.D. Sher, G.D. Ginder, J. Little Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies N Engl J Med 332 1995 1606 1610
27. N.F. Olivieri, D.C. Rees, G.D. Ginder Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley's anemia Ann N Y Acad Sci 850 1998 100 109
28. J.P. Issa Decitabine Curr Opin Oncol 15 2003 446 451
29. R.I. Glazer, M.C. Knode 1-Beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells Mol Pharmacol 26 1984 381 387
30. T. Haaf The effects of 5-azacytidine and 5-azadeoxycytidine on chromosome structure and function Implications for methylation-associated cellular processes Pharmacol Ther 65 1995 19 46
31. Y. Saunthararajah, C.A. Hillery, D. Lavelle Effects of 5-aza-2′-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease Blood 102 2003 3865 3870
32. A. Aparicio, C.A. Eads, L.A. Leong Phase I trial of continuous infusion 5-aza-2′- deoxycytidine Cancer Chemother Pharmacol 51 2003 231 239
33. P.A. Jones, S.M. Taylor Cellular differentiation, cytidine analogs and DNA methylation Cell 20 1980 85 93
34. E.E. Cameron, K.E. Bachman, S. Myohanen Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer Nat Genet 21 1999 103 107
35. M. Ehrlich Expression of various genes is controlled by DNA methylation during mammalian development J Cell Biochem 88 2003 899 910
36. P.A. Jones, D. Takai The role of DNA methylation in mammalian epigenetics Science 293 2001 1068 1070
37. T.J. Ley, J. DeSimone, C.T. Noguchi 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia Blood 62 1983 370 380
38. S. Charache, G. Dover, K. Smith Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex Proc Natl Acad Sci U S A 80 1983 4842 4846
39. D.J. Weatherall Thalassemia in the next millennium. Keynote address Ann N Y Acad Sci 850 1998 1 9
40. B. Modell, M. Khan, M. Darlison Survival in beta-thalassaemia major in the UK Data from the UK Thalassaemia Register Lancet 355 2000 2051 2052